For Zoe Heineman, Head of Commercial of Syntactiq, Type 1 diabetes never remained a personal diagnosis. What began as an unexpected disruption in her early twenties gradually became the defining force behind a career dedicated to expanding access and advancing innovation for people living with chronic disease.
Over the decades, her work has taken her all over the USA, from medical device development to classrooms, to advocacy initiatives, and Medicare policy reform, all driven by a belief that patients deserve more than treatment alone. "They deserve access to the technologies and research that can improve the quality and trajectory of their lives," Heineman says. That mission began shortly after her diagnosis at age 23, when the realities of managing diabetes revealed challenges that extended far beyond medicine itself.
